These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15018439)

  • 41. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
    Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
    Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poor sperm quality affects clinical outcomes of intracytoplasmic sperm injection in fresh and subsequent frozen-thawed cycles: potential paternal effects on pregnancy outcomes.
    Lee SH; Song H; Park YS; Koong MK; Song IO; Jun JH
    Fertil Steril; 2009 Mar; 91(3):798-804. PubMed ID: 18582871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
    Sahu B; Ozturk O; Ranierri M; Serhal P
    Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late stages of embryo progression are a much better predictor of clinical pregnancy than early cleavage in intracytoplasmic sperm injection and in vitro fertilization cycles with blastocyst-stage transfer.
    Rehman KS; Bukulmez O; Langley M; Carr BR; Nackley AC; Doody KM; Doody KJ
    Fertil Steril; 2007 May; 87(5):1041-52. PubMed ID: 17336973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study.
    Ioannidis G; Sacks G; Reddy N; Seyani L; Margara R; Lavery S; Trew G
    Hum Reprod; 2005 Mar; 20(3):741-6. PubMed ID: 15591085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.
    Florêncio RS; Meira MSB; Cunha MVD; Camarço MNCR; Castro EC; Finotti MCCF; Oliveira VA
    JBRA Assist Reprod; 2018 Mar; 22(1):8-14. PubMed ID: 29338136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fertilization, embryo development, and clinical outcome of immature oocytes from stimulated intracytoplasmic sperm injection cycles.
    Shu Y; Gebhardt J; Watt J; Lyon J; Dasig D; Behr B
    Fertil Steril; 2007 May; 87(5):1022-7. PubMed ID: 17261289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The rate at which serum total beta-subunit human chorionic gonadotropin increases after embryo transfer is a predictor of the viability of pregnancy and an identifier of determinants of pregnancy.
    Stone BA; Vargyas JM; Ringler GE; March CM; Marrs RP
    Fertil Steril; 2006 Dec; 86(6):1626-33. PubMed ID: 17081527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The study on the relationship between luteal phase serum sex hormone levels and pregnancy outcome in in vitro fertilization embryo transfer cycle].
    Tian X; Zhang L; Yang C
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):484-6. PubMed ID: 10806749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cryopreserved-thawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study.
    Gelbaya TA; Nardo LG; Hunter HR; Fitzgerald CT; Horne G; Pease EE; Brison DR; Lieberman BA
    Fertil Steril; 2006 Mar; 85(3):603-9. PubMed ID: 16500326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Estrogen role in the luteal phase support in in vitro fertilization with embryo transfer cycles].
    Paredes Chávez FC; Barros Delgadillo JC; Ochoa Rueda SS; Barroso Villa G; Villalobos Acosta S; Sánchez Solís V; Osorio Caballero M; Gaviño Gaviño F
    Ginecol Obstet Mex; 2004 Dec; 72():645-55. PubMed ID: 15813475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
    Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
    Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Follicle-stimulating hormone and estradiol levels independently predict the success of assisted reproductive technology treatment.
    Frazier LM; Grainger DA; Schieve LA; Toner JP
    Fertil Steril; 2004 Oct; 82(4):834-40. PubMed ID: 15482756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-dose depot leuprolide is as efficient as daily short-acting leuprolide in ICSI cycles.
    Isikoglu M; Ozdem S; Berkkanoglu M; Jamal H; Senturk Z; Ozgur K
    Hum Reprod; 2007 Jun; 22(6):1657-61. PubMed ID: 17434884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
    Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
    Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Greater implantation and pregnancy rates with vaginal progesterone in intracytoplasmic sperm injection but not in in vitro fertilization cycles: a retrospective study.
    Manno M; Marchesan E; Cicutto D; Zadro D; Favretti C; Tomei F
    Fertil Steril; 2005 May; 83(5):1391-6. PubMed ID: 15866574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognosis for clinical pregnancy and delivery after total fertilization failure during conventional in vitro fertilization or intracytoplasmic sperm injection.
    Kinzer DR; Barrett CB; Powers RD
    Fertil Steril; 2008 Aug; 90(2):284-8. PubMed ID: 17714711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
    Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
    Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.